APA (7th ed.) Citation

P, K., S, M., P, D., CJ, T., DJ, D., LD, L., . . . X, J. (2026). Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. Molecular genetics and metabolism, 148(3), 110159. https://doi.org/10.1016/j.ymgme.2026.110159

Chicago Style (17th ed.) Citation

P, Kell, et al. "Diagnostic and Therapeutic Applications of the Glycan Biomarker H3N2b in GM1 Gangliosidosis." Molecular Genetics and Metabolism 148, no. 3 (2026): 110159. https://doi.org/10.1016/j.ymgme.2026.110159.

MLA (9th ed.) Citation

P, Kell, et al. "Diagnostic and Therapeutic Applications of the Glycan Biomarker H3N2b in GM1 Gangliosidosis." Molecular Genetics and Metabolism, vol. 148, no. 3, 2026, p. 110159, https://doi.org/10.1016/j.ymgme.2026.110159.